Tyra Biosciences TYRA
NASDAQ TYRA
$20.97 -0.03 (-0.14%)
At close: Nov 11, 2026 · 4:00 PM EST

Tyra Biosciences (TYRA) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Tyra Biosciences (TYRA) posted Return on Capital Employed [ROCE] of -43.01% for Q2 2026, down 4.84 percentage points from -38.17% a year earlier but up 0.55 percentage points from the prior quarter.

Analysis

Tyra Biosciences (TYRA) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Tyra Biosciences' Return on Capital Employed [ROCE] came in at -43.53%, down 6.34 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has declined for four consecutive years, with a four-year change of -26.86 percentage points (FY2021 to FY2025).
  • In prior years, Tyra Biosciences' Return on Capital Employed [ROCE] was -37.19% in FY2024 (-2.54 pp), -34.66% in FY2023 (-13.67 pp), -20.99% in FY2022 (-4.32 pp) and -16.67% in FY2021.
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -48.43% in Q4 2025 to a high of -8.54% in Q4 2021 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined in each of the last six quarters, with an average year-over-year change of -7.23 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2024, with a gain of 7.73 percentage points; the weakest was Q4 2025, with a drop of 19.28 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -43.56% (Q1 2026), -48.43% (Q4 2025) and -42.59% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Tyra Biosciences 1.45 Bn 758.54 Mn - -34.70%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -34.70%
Jun 30, 2026 -43.01%
Mar 31, 2026 -43.56%
Dec 31, 2025 -48.43%
Sep 30, 2025 -42.59%
Jun 30, 2025 -38.17%
Mar 31, 2025 -33.52%
Dec 31, 2024 -29.15%
Sep 30, 2024 -26.75%
Jun 30, 2024 -24.59%
Mar 31, 2024 -28.68%
Dec 31, 2023 -36.88%
Sep 30, 2023 -29.62%
Jun 30, 2023 -23.88%
Mar 31, 2023 -22.74%
Dec 31, 2022 -22.20%
Sep 30, 2022 -19.50%
Jun 30, 2022 -16.28%
Mar 31, 2022 -12.39%
Dec 31, 2021 -8.54%
API Access

Tyra Biosciences Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=TYRA&period=max&api_key=YOUR_API_KEY